looks like more punishment for CSL. i shouldn't have removed my short. my target was $140.
DOW was up 200 points but is currently 400 points down
CSL was overvalued. forward FY18 PE ratio of 38 was too high
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-142
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$309.03 |
Change
0.470(0.15%) |
Mkt cap ! $149.0B |
Open | High | Low | Value | Volume |
$307.48 | $309.17 | $306.25 | $30.77M | 99.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | $309.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$309.02 | 74 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 16 | 308.790 |
2 | 61 | 308.780 |
2 | 28 | 308.770 |
2 | 30 | 308.760 |
3 | 23 | 308.750 |
Price($) | Vol. | No. |
---|---|---|
308.910 | 39 | 6 |
308.920 | 40 | 5 |
308.930 | 54 | 6 |
308.940 | 150 | 7 |
308.950 | 10 | 1 |
Last trade - 11.06am 16/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online